Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2001 1
2002 2
2003 4
2004 2
2007 2
2011 2
2012 7
2013 10
2014 14
2015 22
2016 21
2017 17
2018 19
2019 19
2020 13
2021 20
2022 15
2023 6
2024 8
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

170 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT).
van den Ende T, de Clercq NC, van Berge Henegouwen MI, Gisbertz SS, Geijsen ED, Verhoeven RHA, Meijer SL, Schokker S, Dings MPG, Bergman JJGHM, Haj Mohammad N, Ruurda JP, van Hillegersberg R, Mook S, Nieuwdorp M, de Gruijl TD, Soeratram TTD, Ylstra B, van Grieken NCT, Bijlsma MF, Hulshof MCCM, van Laarhoven HWM. van den Ende T, et al. Among authors: meijer sl. Clin Cancer Res. 2021 Jun 15;27(12):3351-3359. doi: 10.1158/1078-0432.CCR-20-4443. Epub 2021 Jan 27. Clin Cancer Res. 2021. PMID: 33504550 Clinical Trial.
Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study.
Noordman BJ, Spaander MCW, Valkema R, Wijnhoven BPL, van Berge Henegouwen MI, Shapiro J, Biermann K, van der Gaast A, van Hillegersberg R, Hulshof MCCM, Krishnadath KK, Lagarde SM, Nieuwenhuijzen GAP, Oostenbrug LE, Siersema PD, Schoon EJ, Sosef MN, Steyerberg EW, van Lanschot JJB; SANO study group. Noordman BJ, et al. Lancet Oncol. 2018 Jul;19(7):965-974. doi: 10.1016/S1470-2045(18)30201-8. Epub 2018 Jun 1. Lancet Oncol. 2018. PMID: 29861116
Estrogen-related receptor alpha drives mitochondrial biogenesis and resistance to neoadjuvant chemoradiation in esophageal cancer.
Dings MPG, van der Zalm AP, Bootsma S, van Maanen TFJ, Waasdorp C, van den Ende T, Liu D, Bailey P, Koster J, Zwijnenburg DA, Spek CA, Klomp JPG, Oubrie A, Hooijer GKJ, Meijer SL, van Berge Henegouwen MI, Hulshof MC, Bergman J, Oyarce C, Medema JP, van Laarhoven HWM, Bijlsma MF. Dings MPG, et al. Among authors: meijer sl. Cell Rep Med. 2022 Nov 15;3(11):100802. doi: 10.1016/j.xcrm.2022.100802. Epub 2022 Nov 4. Cell Rep Med. 2022. PMID: 36334593 Free PMC article.
A full stomach.
Kager LM, Meijer SL, Bastiaansen BA. Kager LM, et al. Among authors: meijer sl. Gastroenterology. 2014 Nov;147(5):974-6. doi: 10.1053/j.gastro.2014.06.003. Epub 2014 Sep 20. Gastroenterology. 2014. PMID: 25252015 No abstract available.
Targeted therapy for advanced esophagogastric adenocarcinoma.
Kordes S, Cats A, Meijer SL, van Laarhoven HW. Kordes S, et al. Among authors: meijer sl. Crit Rev Oncol Hematol. 2014 Apr;90(1):68-76. doi: 10.1016/j.critrevonc.2013.10.004. Epub 2013 Oct 12. Crit Rev Oncol Hematol. 2014. PMID: 24183912 Review.
Allogeneic breast cancer cell vaccines.
Dols A, Meijer SL, Smith JW 2nd, Fox BA, Urba WJ. Dols A, et al. Among authors: meijer sl. Clin Breast Cancer. 2003 Feb;3 Suppl 4:S173-80. doi: 10.3816/cbc.2003.s.008. Clin Breast Cancer. 2003. PMID: 12620156 Review.
Tumor immune microenvironmental characteristics in Human Epidermal Growth Factor-2 (HER2) positive esophageal adenocarcinoma: A comparative analysis and biomarker study.
Stroes CI, Meijer SL, Creemers GJ, Hooijer GKJ, Mohammad NH, Los M, Slingerland M, Hospers GAP, Cats A, Beerepoot LV, Bijlsma MF, van Laarhoven HWM. Stroes CI, et al. Among authors: meijer sl. Transl Oncol. 2024 Nov;49:102079. doi: 10.1016/j.tranon.2024.102079. Epub 2024 Aug 15. Transl Oncol. 2024. PMID: 39151279 Free PMC article.
Outcomes after radical endoscopic resection of high risk T1 esophageal adenocarcinoma: an international multicenter retrospective cohort study.
Chan MW, Haidry R, Norton B, di Pietro M, Hadjinicolaou AV, Barret M, Doumbe Mandengue P, Seewald S, Bisschops R, Nafteux P, Bourke MJ, Gupta S, Mundre P, Lemmers A, Vuckovic C, Pech O, Leclercq P, Coron E, Meijer SL, Bergman JJGHM, Pouw RE. Chan MW, et al. Among authors: meijer sl. Endoscopy. 2025 Jul;57(7):699-708. doi: 10.1055/a-2538-9316. Epub 2025 Feb 13. Endoscopy. 2025. PMID: 39947641 Free PMC article.
170 results